VANCOUVER, British Columbia--()--The Centre for Drug Research and Development (CDRD) today announced the “Western Canada Innovation Agreement” which brings together CDRD, the Province of British Columbia, the Province of Alberta, and Johnson &Johnson Corporate Office of Science and Technology (COSAT) to jointly develop and manage a fund to support innovative health research programs in the life sciences sector.
“Alberta is focused on increasing its research capacity and on ensuring that new discoveries make it from the lab to the patient”
The Western Canada Innovation Agreement provides for a joint steering committee that will oversee a co-managed seed fund to enable early-stage, smart discoveries within the health sciences so that they may advance along a pathway to commercialization. Representatives from Alberta, British Columbia/CDRD and COSAT will jointly assess opportunities for the collaboration, funding, management, and commercialization of innovative health research projects.
“CDRD is pleased to have the support of the Province of British Columbia as we enter into this partnership. By developing an integrated, collaborative and strategic approach to research and innovation, we can further leverage the world-class research within Western Canada and CDRD’s drug development expertise in order to commercialize new medical technologies and therapeutics,” said Karimah Es Sabar, Senior Vice President, Business and Strategic Affairs for CDRD.
“British Columbia is a strong supporter of these collaborative efforts to further advance early-stage drug development and the commercialization of scientific research in human health from our universities,” said Ida Chong, B.C.’s Minister of Science and Universities. “The signing of this new agreement is an important step forward in furthering these goals.”
“Alberta is focused on increasing its research capacity and on ensuring that new discoveries make it from the lab to the patient,” said Alberta’s Minister of Advanced Education and Technology, Doug Horner. “Partnerships like this one – that give us access to new expertise, new facilities, and new markets – will be important to our future success.”
“Collaborations like these are part of our strategy to establish our research presence around the globe,” said Dr. Garry Neil, Corporate Vice President, COSAT, Johnson & Johnson. “Ventures like these will create an opportunity for advancements in innovative research within a talent-rich environment.”
For more information on COSAT, visit www.jnjcosat.com/cosat.
The Centre for Drug Research and Development (CDRD) (www.cdrd.ca) provides drug development expertise and infrastructure to enable researchers from leading academic and health research institutions to advance promising, early-stage drug candidates. CDRD combines its drug development platform with a commercial arm, which licenses technologies from affiliated institutions and establishes working collaborations with other biotech and life sciences companies. The Government of Canada's Networks of Centres of Excellence program has recognized CDRD as a Centre of Excellence in Commercialization in Research (CECR).
About Alberta Advanced Education and Technology
In collaboration with Campus Alberta and Alberta Innovates partners, Advanced Education and Technology strives to build a prosperous province through a dynamic and integrated learning and innovation system built on a foundation of highly skilled people in support of a knowledge-based economy and society in Alberta.